SVELTE MEDICAL SYSTEMS INC

Profile

Company Names

SVELTE MEDICAL SYSTEMS INC

Addresses

675 CENTRAL AVENUE, SUITE 2, NEW PROVIDENCE, NJ 07974

127 MAIN STREET, CHATHAM, NJ 07928

675 CENTRAL AVENUE, NEW PROVIDENCE, NJ 07974

Phone Numbers

908-264-2195
908-264-2194

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER HEALTH CARE

Year Incorporated:

2007

State Incorporated:

DE

Total Amount Raised:

$119,355,823.00

Number of Funding Rounds:

10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2021-04-23 
$5,445,363.00 
$10,845,671.00 
$5,400,308.00 
Equity 
9
2017-11-15 
$3,000,000.00 
$52,000,000.00 
$49,000,000.00 
Equity 
8
2016-07-21 
$12,300,000.00 
$15,000,000.00 
$2,700,000.00 
Debt 
7
2013-10-28 
$50,402,467.00 
$50,796,673.00 
$394,206.00 
Equity 
6
2013-04-18 
$4,307,884.00 
$5,470,329.00 
$1,162,445.00 
Debt 
5
2012-06-08 
$5,000,000.00 
$7,000,000.00 
$2,000,000.00 
Debt 
4
2011-12-01 
$18,784,666.00 
$35,000,000.00 
$16,215,334.00 
Equity 
3
2010-10-14 
$9,694,400.00 
$12,000,000.00 
$2,305,600.00 
Debt 
2
2009-11-17 
$4,151,043.00 
$10,000,000.00 
$5,848,957.00 
Equity 
1
2009-01-29 
$6,270,000.00 
$8,000,000.00 
$1,730,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAN 
 
BOWEN 
DIRECTOR
JANET 
 
BURPEE 
EXECUTIVE OFFICER
STEVE 
 
BURPEE 
DIRECTOR
MICHAEL 
 
CAPONETTO 
DIRECTOR
ROBERT 
 
CROCE 
DIRECTOR, EXECUTIVE OFFICER
RICHARD 
 
DAKERS 
DIRECTOR
JACK 
 
DARBY 
EXECUTIVE OFFICER, DIRECTOR
FERNANDO 
 
DI CAPRIO 
EXECUTIVE OFFICER, DIRECTOR
DAVID 
 
FISCHELL 
EXECUTIVE OFFICER, DIRECTOR
DAVID 
FISCHELL 
DIRECTOR
DAVID 
R. 
FISCHELL 
DIRECTOR
ROBERT 
 
FISCHELL 
EXECUTIVE OFFICER, DIRECTOR
ROBERT 
FISCHELL 
EXECUTIVE OFFICER, DIRECTOR
ROBERT 
E. 
FISCHELL 
EXECUTIVE OFFICER, DIRECTOR
TIM 
FISCHELL 
EXECUTIVE OFFICER
TIM 
A. 
FISCHELL 
EXECUTIVE OFFICER, DIRECTOR
ROBERT 
 
FLANAGAN 
DIRECTOR
MICHAEL 
 
JOHNSON 
EXECUTIVE OFFICER
WELLKEEPER INC   |  GOLDMAN SACHS COMMODITY OPPORTUNITIES FUND LLC   |  GOLDMAN SACHS GLOBAL OPPORTUNITIES FUND OFFSHORE LTD   |  MOTION COMPUTING INC   |  EMPIRE MINING CORP   |  GOLDMAN SACHS COMMODITY OPPORTUNITIES FUND OFFSHORE LTD   |  SVELTE MEDICAL SYSTEMS INC   |  GOLDMAN SACHS GLOBAL OPPORTUNITIES FUND LLC   |  BIOENERGY HOLDING LLC   |  MYRIANT TECHNOLOGIES LLC   |  APTERA MOTORS, INC.   |  CAMSTAR SYSTEMS INC   |  SCENIC TECHNOLOGY CORP   |  24PAGEBOOKS, INC   |  SILVER SUN RESOURCE CORP.   |  BIZTAG, LLC   |  JBI LOW CORRELATION FUND, LLC   |  SSH INVESTORS LLC   |  OOMBA, INC.   |  SLATER MINING CORP   |  FLUX POWER HOLDINGS, INC.   |  GLOBAL OPPORTUNITIES LLC   |  COMMODITY OPPORTUNITIES PARTNERS LTD   |  COMMODITY OPPORTUNITIES PARTNERS LLC   |  DOOLEY-S PETROLEUM, INC.   |  DOOLEY BROS LLP   |  DOOLEY-S NATURAL GAS, LLC   |  DOOLEY-S NATURAL GAS II, LLC   |  ALLIANCE MIDSTREAM LLC   |  LOCUS ROBOTICS CORP.   |  SEA MACHINES ROBOTICS, INC.   |  CAMPAIGN MONITOR HOLDINGS (UK) LTD   |  SECURED FIXED INCOME FUND, LLC   |  VIRTUAL FITNESS TECHNOLOGIES, INC   |  OCULUS VISIONTECH INC.   |  URBANCORE PRESERVATION - GROVE, LP   |  URBANCORE PRESERVATION - REDWOOD, LP   |  URBANCORE PRESERVATION - 40TH STREET, LP   |  ADVANCED THERMOVOLTAIC SYSTEMS, LLC   |  COIN + CARD AUCTIONS, INC   |  ASD.ME, LLC   |  IDEOLOGI DEVELOPMENT, INC.   |  RHINOMED HEALTH CORP   |  EIGENQ INC   |  ROSE MANAGEMENT GROUP INC.   |  INFINANT HEALTH, INC.
MARK 
 
KIELEK 
EXECUTIVE OFFICER
MARK 
KIELEK 
EXECUTIVE OFFICER
MARK 
A. 
KIELEK 
EXECUTIVE OFFICER
TIMOTHY 
 
LASH 
DIRECTOR
MARK 
 
POMERANZ 
EXECUTIVE OFFICER, DIRECTOR
MINA 
SOOCH 
DIRECTOR
MINA 
P. 
SOOCH 
DIRECTOR
RICHARD 
SPENCER 
EXECUTIVE OFFICER
RICHARD 
T. 
SPENCER 
EXECUTIVE OFFICER
PHILLIP 
TORRENCE 
EXECUTIVE OFFICER
PHILLIP 
D. 
TORRENCE 
EXECUTIVE OFFICER
NICHOLAS 
 
VALERIANI 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-04-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-15 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-07-21 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-10-28 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-07-21 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-10-28 
D/A
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2013-10-28 
D/A
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2013-10-28 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2013-10-28 
D/A
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Debt 
2013-04-18 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Debt 
2013-04-18 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Debt 
2012-06-08 
D
OTHER HEALTH CARE 
 
$1 - $1,000,000 
Equity 
2011-12-01 
D/A
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Debt 
2010-10-14 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Debt 
2010-10-14 
D/A
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2009-11-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-11-17 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-01-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
PIPER JAFFRAY + CO.
655